Optiver invests in Brazilian derivatives exchange A5X
Optiver is pleased to announce its strategic investment in A5X, a Brazilian exchange focused on derivatives and futures that aims to begin operations in 2026.
Alongside a previous funding round, the Series B round will enable A5X to fund the investment in talent and technology necessary for its launch. A5X plans to offer trading and post-trading solutions for derivatives markets in Brazil.
Optiver, a leading global market maker, has been providing liquidity in Brazil for over 12 years, and in that time the country’s capital markets have experienced significant growth. Recent developments include the launch of weekly options on single stocks and ETFs, bringing one of the fastest growing products in global derivatives markets to investors in Brazil.
“Our investment in A5X is a vote of confidence in Brazil’s capital markets, among the most exciting and rapidly developing in the world,” said Ed Monrad, head of corporate strategy at Optiver. “With our long history in Brazil, Optiver is committed to advancing this next stage of growth, which will fuel innovation, bring additional capacity and result in healthy choice for all participants.”
The investment is an initiative of Optiver’s Principal Strategic Investments (PSI) team, which forms long-term strategic relationships with companies linked to our core mission of improving the market. The aim is to impart our knowledge and philosophy to the companies we invest in.
For more information contact [email protected]
About Optiver
Optiver is a global market maker founded in Amsterdam, with offices in London, Chicago, Austin, New York, Sydney, Shanghai, Hong Kong, Singapore, Taipei and Mumbai. Established in 1986, today we are a leading liquidity provider, with close to 2,000 employees in offices around the world, united in our commitment to improve the market through competitive pricing, execution and risk management. By providing liquidity on multiple exchanges across the world in various financial instruments we participate in the safeguarding of healthy and efficient markets. We provide liquidity to financial markets using our own capital, at our own risk, trading a wide range of products: listed derivatives, cash equities, ETFs, bonds and foreign currencies.